Richard A. Young, Director at Syros Pharmaceuticals, Inc. (SYRS), sold 25,000 shares at $10.00 ($250K) on 2019-08-16, disclosed to the SEC on 2019-08-19.
Open-market sale of $250k SYRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.00 | 2,300 | $23K | 9.2% |
| 2 | $10.00 | 22,700 | $227K | 90.8% |
| Total | $10.00 avg | 25,000 | $250K | 100% |
| Filing → |
| OMGA | SELL | 2023-06-05 | $40K | — | Filing → |
| OMGA | SELL | 2023-05-03 | $40K | — | Filing → |
| OMGA | SELL | 2023-04-10 | $40K | — | Filing → |